塞栓用粒子市場：市場規模（セグメント別）、シェア、規制、償還、手技、予測（～2033年）

塞栓用粒子は、粒子を用いた塞栓療法は低侵襲な処置であり、開腹手術の代替として使用されます。これは、身体の特定部位への血液の流れを遮断することで機能します。その結果、動脈瘤や腫瘍が縮小します。塞栓用粒子は、組成と作用機序に基づいて4つのセグメントに分類することができます（ポリビニルアルコール（PVA）粒子、微小球、薬剤溶出ビーズ、放射性塞栓粒子）。粒子の選択は主に、患者の年齢、携帯性、装置のコスト、治療の種類によって決まります。

当レポートは、世界の塞栓用粒子市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、COVID-19の影響、地域、国別の動向などを提供しています。

目次

現在上市されている塞栓用粒子と競合情勢

• 主要な業界動向の洞察
• 塞栓用粒子のセグメント別総市場収益と2015年～2033年の市場展望
• セグメント別の手技総数、個数、平均販売価格、市場価値に関する詳細データ

世界、地域、国別の洞察

• 塞栓用粒子市場のSWOT分析
• 塞栓用粒子市場に関する競合力学の洞察と動向
• 国別の医療制度の概要
• 国別の償還政策
• 国別の医療技術に関する規制の状況

List of Tables

Not Applicable

List of Figures

Not Applicable

Abstract

Embolization Particles Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within General Surgery Devices therapeutic area.

Embolotherapy with particles is a minimally invasive procedure and is used as an alternative to open surgery. This works by blocking the flow of blood to a particular area of the body. This results in the shrinkage of an aneurysm or tumor. Embolization particles can be categorized into four segments based on composition and mechanism of action: Polyvinyl Alcohol (PVA) Particles, Microspheres, Drug-Eluting Beads, Radioembolization Particles. Choice of particles mainly depends on patient age, portability, cost of the device and treatment type.

Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Embolization Particles and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Embolization Particles market revenue by segment and market outlooks from 2015-2033.
• Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Embolization Particles market.
• Competitive dynamics insights and trends provided for Embolization Particles market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Boston Scientific Corp, Merit Medical Systems Inc, CDH Investment Management Company Limited, Terumo Corp, Cook Group Inc, Siemens Healthineers AG, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Embolization Particles marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Understand the impact of COVID-19 on Embolization Particles market.
• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
• Develop business strategies by understanding the trends shaping and driving Embolization Particles market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Embolization Particles market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Embolization Particles market from 2015-2033.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

Not Applicable